|
Diabetes, Vol 48, Issue 2 267-271, Copyright © 1999 by American Diabetes Association
Altered energy balance causes selective changes in melanocortin-4(MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: further evidence that activation of MC4-R is a physiological inhibitor of feeding
JA Harrold, PS Widdowson and G Williams
Department of Medicine, University of Liverpool, UK. harrold@liverpool.ac.uk
We have examined the effects of underfeeding and obesity on the density of
hypothalamic melanocortin MC3 and MC4 receptors (MC3-R and MC4-R,
respectively), which may mediate the hypophagic effects of
alpha-melanocyte-stimulating hormone (MSH) in the rat. MC3-R and MC4-R were
measured by quantitative autoradiography in brain sections using
125I-labeled Nle4-D-Phe7-alpha-MSH (125I-NDP-MSH) and discriminated by
masking MC3-R with excess unlabelled gamma2-MSH. High densities of MC4-R
occurred in the ventromedial (VMH) and arcuate (ARC) nuclei, median
eminence (ME), and medial habenular nucleus (MHb), with lower densities in
the dorsomedial hypothalamus (DMH) and forebrain regions. MC3-R were
confined to the VMH, ARC, and MHb. After 10-days of food restriction (14%
weight loss), density of MC4-R was significantly increased by 20-65% in the
VMH, ARC, ME, and DMH, with no changes elsewhere. Similarly, obese (fa/fa)
Zucker rats showed 43-98% increases in MC4-R in the same regions. By
contrast, rats with diet-induced obesity (18% heavier than controls) showed
significantly decreased binding to MC4-R, especially in the VMH, ARC, and
ME. MC3-R showed no significant alterations in any model. We suggest that
increased density of MC4-R with food restriction and in obese Zucker rats
reflects receptor upregulation secondary to decreased release of alpha-MSH,
consistent with increased hunger in these models. Conversely,
downregulation of MC4-R in diet-induced obesity may indicate increased
alpha-MSH secretion in an attempt to limit overeating. This alpha-MSH/MC4-R
system may be inhibited by leptin and/or insulin. MC3-R are not apparently
involved in regulating feeding.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. A. Smith, K. Hisadome, H. Al-Qassab, H. Heffron, D. J. Withers, and M. L. J. Ashford
Melanocortins and agouti-related protein modulate the excitability of two arcuate nucleus neuron populations by alteration of resting potassium conductances
J. Physiol.,
January 15, 2007;
578(2):
425 - 438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Stanley, K. Wynne, B. McGowan, and S. Bloom
Hormonal Regulation of Food Intake
Physiol Rev,
October 1, 2005;
85(4):
1131 - 1158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Blondet, J Gout, P Durand, M Begeot, and D Naville
Expression of the human melanocortin-4 receptor gene is controlled by several members of the Sp transcription factor family
J. Mol. Endocrinol.,
April 1, 2005;
34(2):
317 - 329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Wynne, S. Stanley, B. McGowan, and S. Bloom
Appetite control
J. Endocrinol.,
February 1, 2005;
184(2):
291 - 318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. A. Verty, J. R. McFarlane, I. S. McGregor, and P. E. Mallet
Evidence for an Interaction between CB1 Cannabinoid and Melanocortin MCR-4 Receptors in Regulating Food Intake
Endocrinology,
July 1, 2004;
145(7):
3224 - 3231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Li, C. V. Mobbs, and P. J. Scarpace
Central Pro-opiomelanocortin Gene Delivery Results in Hypophagia, Reduced Visceral Adiposity, and Improved Insulin Sensitivity in Genetically Obese Zucker Rats
Diabetes,
August 1, 2003;
52(8):
1951 - 1957.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Shinyama, H. Masuzaki, H. Fang, and J. S. Flier
Regulation of Melanocortin-4 Receptor Signaling: Agonist-Mediated Desensitization and Internalization
Endocrinology,
April 1, 2003;
144(4):
1301 - 1314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Baran, E. Preston, D. Wilks, G. J. Cooney, E. W. Kraegen, and A. Sainsbury
Chronic Central Melanocortin-4 Receptor Antagonism and Central Neuropeptide-Y Infusion in Rats Produce Increased Adiposity by Divergent Pathways
Diabetes,
January 1, 2002;
51(1):
152 - 158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. G. Kokkotou, N. A. Tritos, J. W. Mastaitis, L. Slieker, and E. Maratos-Flier
Melanin-Concentrating Hormone Receptor Is a Target of Leptin Action in the Mouse Brain
Endocrinology,
February 1, 2001;
142(2):
680 - 686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Small, M. S. Kim, S. A. Stanley, J. R.D. Mitchell, K. Murphy, D. G.A. Morgan, M. A. Ghatei, and S. R. Bloom
Effects of Chronic Central Nervous System Administration of Agouti-Related Protein in Pair-Fed Animals
Diabetes,
February 1, 2001;
50(2):
248 - 254.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Inui
Transgenic Approach to the Study of Body Weight Regulation
Pharmacol. Rev.,
March 1, 2000;
52(1):
35 - 62.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Diabetes Association.
|
|
| |
|